Talc slurry versus talc powder for lung pluerodesis
Part of Cancer, Lungs & breathing clinical trials.
This study compares two ways to treat fluid buildup or air leaks in the chest—using a liquid talc mixture or talc powder blown in. It aims to find which method works better and is safer for people with cancer-related fluid or a collapsed lung.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years or older.
- You have fluid in the lung from cancer or a collapsed lung (pneumothorax).
- You are active enough to do daily tasks (ECOG status 0–2).
- Your doctor expects you to live at least 3 more months.
- You are able to give consent and do not have a chest infection or severe breathing problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with a collapsed lung (pneumothorax) that has a persistent air leak. It tests whether talc or a blood patch can seal the leak and help the lung re-inflate.
This trial is testing a small chest tube drainage method for people with fluid buildup around the lung. It may help prevent the fluid from returning, especially if you have a condition like cancer.
This trial looks at how your body position during a procedure called pleurodesis (which helps prevent fluid from building up around your lungs) affects the outcome. It may help if you have fluid in the chest caused by cancer and are scheduled for this treatment.
This trial tests whether using non-steroidal anti-inflammatory drugs (NSAIDs) during pleurodesis (a procedure to seal the lung lining) helps people with a collapsed lung (pneumothorax). It aims to see if these drugs can improve outcomes.
This trial tests whether a talc procedure to seal the lung (pleurodesis) can be done safely in an outpatient setting for people with fluid buildup from cancer. It aims to make the treatment more convenient.
This trial compares two treatments for fluid buildup around the lungs caused by cancer. It tests if a medicine (bleomycin) or a minor procedure (mechanical abrasion) works better to stop the fluid from coming back, helping you breathe easier and improve your quality of life.
Hear when a new Pneumothorax Spontaneous Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.